These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21656049)

  • 1. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
    Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
    Tsujikawa T; Yoshida Y; Mori T; Kurokawa T; Fujibayashi Y; Kotsuji F; Okazawa H
    Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
    Yamamoto M; Tsujikawa T; Yamada S; Kurokawa T; Shinagawa A; Chino Y; Mori T; Kiyono Y; Okazawa H; Yoshida Y
    Oncotarget; 2017 Apr; 8(14):22581-22589. PubMed ID: 28186981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Yamane T; Takaoka A; Kita M; Imai Y; Senda M
    Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
    Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H
    J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an
    Tsujikawa T; Yamamoto M; Shono K; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Okazawa H; Yoshida Y
    Ann Nucl Med; 2017 Dec; 31(10):752-757. PubMed ID: 28905201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
    Tsujikawa T; Yoshida Y; Kiyono Y; Kurokawa T; Kudo T; Fujibayashi Y; Kotsuji F; Okazawa H
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):37-45. PubMed ID: 20717823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
    Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose uptake in uterine leiomyomas in healthy women.
    Tsukada H; Murakami M; Shida M; Kikuchi K; Watanabe M; Yasuda S; Suzuki Y
    Clin Imaging; 2009; 33(6):462-7. PubMed ID: 19857807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
    Ak I; Ozalp S; Yalçin OT; Zor E; Vardareli E
    Nucl Med Commun; 2004 Sep; 25(9):941-5. PubMed ID: 15319600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Ma Y; Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 FDG PET in detecting uterine leiomyoma.
    Lin CY; Ding HJ; Chen YK; Liu CS; Lin CC; Kao CH
    Clin Imaging; 2008; 32(1):38-41. PubMed ID: 18164393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
    Nagamatsu A; Umesaki N; Li L; Tanaka T
    Oncol Rep; 2010 Apr; 23(4):1069-76. PubMed ID: 20204293
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
    Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of FDG PET/CT findings of uterine tumors.
    Kitajima K; Murakami K; Kaji Y; Sugimura K
    AJR Am J Roentgenol; 2010 Sep; 195(3):737-43. PubMed ID: 20729454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.
    Shida M; Murakami M; Tsukada H; Ishiguro Y; Kikuchi K; Yamashita E; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2007; 17(1):285-90. PubMed ID: 17291269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.